Skip to content
Find Clinical Trials
Home » Find Clinical Trials » Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack. The PERFORM Study. An international, randomised, double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally for a 3-year mean duration (event driven trial). – PERFORM

Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack. The PERFORM Study. An international, randomised, double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally for a 3-year mean duration (event driven trial). – PERFORM

Share Print
Servier Protocol Code: CL3-18886-012 Sponsor: Institut de Recherches Internationales Servier (I.R.I.S) EudraCT Number: 2005-003700-10

Find a recruiting site

Name: Institut de Recherches Internationales Servier, Département des études cliniques
Phone number: +33 1 55 72 60 00
Results
English (USA)
Interventions / Treatments
  • Stroke
  • S018886
  • TERUTROBAN
Other study id numbers
  • CL3-18886-012